Outlook Therapeutics Inc (XTER:41O) Stock News, Headlines & Updates
Outlook Therapeutics Inc Stock News from GuruFocus
- 1
Jun 11, 2024
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
Marketwired • 9:00am
May 28, 2024
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Marketwired • 8:00am
May 17, 2024
Outlook Therapeutics Inc (OTLK) Q2 2024 Earnings Call Transcript Highlights: Strategic Moves and Financial Fortitude
GuruFocus Research • 1:01am
Q2 2024 Outlook Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:09pm
May 13, 2024
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
Marketwired • 8:00am
May 09, 2024
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
Marketwired • 8:00am
May 02, 2024
Outlook Therapeutics® to Present at the Retina World Congress 2024
Marketwired • 9:00am
Apr 29, 2024
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Marketwired • 8:00am
Apr 15, 2024
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Marketwired • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news